Diabetic Foot Ulcer Treatment Market Expected to Reach $7.4 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Diabetic Foot Ulcer Treatment Market," The diabetic foot ulcer treatment market size was valued at $4.4 billion in 2022, and is estimated to reach $7.4 billion by 2032, growing at a CAGR of 5.4% from 2023 to 2032. Diabetic foot ulcers (DFUs) are chronic wounds that develop on the feet of individuals with diabetes. They are a common and serious complication of diabetes mellitus, resulting from a combination of factors, including peripheral neuropathy (nerve damage) and peripheral arterial disease (poor blood circulation).

The diabetic foot ulcer treatment market trends is driven by factors such as the increasing prevalence of diabetes, growing number of diabetic foot ulcer cases, advancements in medical technology, and the emphasis on early detection and comprehensive management. The rising global prevalence of diabetes is a major driver for the market growth. For instance, according to National Diabetes Statistics Report by Centers for Disease Control and Prevention (CDC), 2022, about 37.3 million people suffer from diabetes in the U.S. As the number of people with diabetes continues to grow, so does the risk of developing diabetic foot ulcers, leading to higher demand for effective treatment options.

In addition, increasing number of diabetic foot ulcer cases necessitates a robust healthcare infrastructure and specialized facilities for proper diagnosis and treatment. Healthcare systems have responded by developing specialized diabetic foot clinics, wound care centers and multidisciplinary teams comprising podiatrists, endocrinologists, vascular surgeons, and wound care specialists. These specialized facilities and healthcare professionals contribute to the overall management and treatment of diabetic foot ulcer, thereby, supporting the growth of the market.

Further, the availability of various treatment options enables healthcare professionals to address multiple aspects of diabetic foot ulcer management, including wound debridement, infection control, moisture balance, off-loading, and tissue regeneration. This comprehensive approach enhances the healing process, reduces the risk of complications, and improves patient quality of life.

Moreover, access to healthcare services plays a crucial role in addressing the growing number of diabetic foot ulcer cases. Efforts to improve access, particularly in developing regions have contributed to early detection and timely intervention. Increased awareness campaigns, community outreach programs, and telemedicine initiatives have played a significant role in reaching individuals with diabetic foot ulcer in remote areas and providing them with appropriate care. The improved access to healthcare services ensures that more diabetic foot ulcer cases are identified and treated, contributing to the growth of the market.

Further, advances in medical technology have greatly influenced the diabetic foot ulcer treatment market. The development of innovative wound care products, negative pressure wound therapy (NPWT) devices, bioengineered skin substitutes, off-loading devices, and advanced dressings has improved the efficacy and outcomes of treatment. These technological advancements have enhanced the healing process and provided better management options for diabetic foot ulcers.

Negative pressure wound therapy (NPWT) devices have gained popularity for diabetic foot ulcer treatment owing to their effectiveness in promoting wound healing. These devices create a vacuum environment that helps remove excess fluid, debris, and bacteria from the wound while promoting blood flow and tissue growth. Examples of FDA-approved NPWT devices for diabetic foot ulcer are V.A.C. Therapy of 3M Company and PICO from Smith & Nephew.

Furthermore, increasing prevalence of diabetes has prompted a greater emphasis on prevention and early intervention strategies. Healthcare organizations and professionals are increasingly focusing on educating patients about foot care, regular check-ups, and the importance of managing diabetes effectively to reduce the risk of diabetic foot ulcers. This heightened awareness has led to increased screening, early detection, and timely treatment of foot ulcers, driving the demand for diabetic foot ulcer treatment options.

Moreover, increasing healthcare expenditure, particularly in developing countries, has a direct influence on the diabetic foot ulcer treatment market. As healthcare budgets expand, there is a greater allocation of resources to address chronic conditions, such as diabetes and its complications. This drives the demand for diabetic foot ulcer treatments and encourages investment in the development of new therapies.

However, high treatment cost and stringent government regulations are the major factors which restrain the growth of the diabetic foot ulcer treatment market. Diabetic foot ulcer treatment can be costly, especially when considering the long duration of treatment and the need for multiple interventions. The expenses associated with wound care products, advanced dressings, biologics, devices, and surgical procedures can impose financial burdens on patients and healthcare systems.

On the basis of product, the market is categorized into wound care dressings, wound care devices, biologics, and others. The wound care devices segment is further categorized into negative pressure wound therapy and others. The wound care dressings segment accounted for largest diabetic foot ulcer treatment market share in 2022, owing to rise in number of key players offering advanced wound care dressings, rise in regulatory approvals, and growing awareness about wound care dressings in diabetic foot ulcer treatment. The wound care devices segment is anticipated to witness highest CAGR during the forecast period owing to rise in adoption of wound care devices, ongoing advancements in wound care devices, and demonstrated effectiveness of devices in promoting faster healing.

Based on type, the market is categorized into neuropathic ulcers, ischemic ulcers, and neuroischemic ulcers. The neuroischemic ulcers accounted for largest diabetic foot ulcer treatment market share in 2022, and is anticipated to register highest CAGR during forecast period, owing to increasing prevalence of neuroischemic ulcer type in diabetic population.

On the basis of end user, the diabetic foot ulcer treatment market analysis is categorized into hospitals, homecare settings, and others. The homecare settings segment accounted for largest share in 2022, is projected to register highest CAGR during forecast period, owing to shift in diabetic foot ulcer treatment to homecare settings and adoption of telemedicine and remote care technologies. In addition, many individuals with diabetic foot ulcers receive ongoing care and treatment at home, facilitated by healthcare professionals or caregivers, and also provide convenience and comfort for patients while reducing the burden on healthcare facilities.

Region wise, North America accounted for largest diabetic foot ulcer treatment market size in terms of revenue in 2022. This growth is attributed to factors such as rise in prevalence of diabetic foot ulcers, availability of well-developed healthcare infrastructure such as specialized wound care centers & diabetic clinics, and growing emphasis on early detection & comprehensive management of diabetic foot ulcers. In addition, the increase in the geriatric population in North America has led to a higher prevalence of diabetic foot ulcer, leading to increased demand for novel treatment options.

Moreover, North American healthcare system has made significant investments in improving healthcare infrastructure and facilities, which has enabled better access to healthcare services and treatments for patients with diabetes. However, Asia-Pacific is expected to witness highest growth during the forecast period, owing to rising prevalence of diabetes, increasing healthcare expenditure, and increasing awareness about the importance of early detection and treatment of diabetic foot ulcer which is also expected to boost the diabetic foot ulcer treatment industry.  

Key Findings of the Study

• On the basis of product, the wound care dressings segment dominated the market in terms of revenue in 2022. However, the wound care devices segment is expected to grow at the highest CAGR during the forecast period.
• Based on type, the neuroischemic ulcers segment accounted for largest share in terms of revenue in 2022 and is anticipated to witness highest CAGR during the diabetic foot ulcer treatment market forecast period.
• On the basis of end user, the homecare settings segment dominated the diabetic foot ulcer treatment industry in terms of revenue in 2022, and is anticipated to grow at the highest CAGR during the forecast period.
• Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.